Marine Drugs (May 2022)

Talaromarins A–F: Six New Isocoumarins from Mangrove-Derived Fungus <i>Talaromyces flavus</i> TGGP35

  • Jin Cai,
  • Xiao-Chen Zhu,
  • Wei-Nv Zeng,
  • Bin Wang,
  • You-Ping Luo,
  • Jing Liu,
  • Min-Jing Chen,
  • Gao-Yu Li,
  • Guo-Lei Huang,
  • Guang-Ying Chen,
  • Jing Xu,
  • Cai-Juan Zheng

DOI
https://doi.org/10.3390/md20060361
Journal volume & issue
Vol. 20, no. 6
p. 361

Abstract

Read online

Six new isocoumarin derivative talaromarins A-F (1–6), along with 17 known analogues (7–23), were isolated from the mangrove-derived fungus Talaromyces flavus (Eurotiales: Trichocomaceae) TGGP35. Their structures were identified by detailed IR, UV, 1D/2D NMR and HR-ESI-MS spectra. The absolute configurations of new compounds were determined by the modified Mosher’s method and a comparison of their CD spectra with dihydroisocoumarins described in the literature. The antioxidant, antibacterial, anti-phytopathogenic and inhibitory activity against α-glucosidase of all the isolated compounds were tested. Compounds 6–11, 17–19 and 21–22 showed similar or better antioxidant activity than the IC50 values ranging from 0.009 to 0.27 mM, compared with the positive control trolox (IC50 = 0.29 mM). Compounds 10, 18, 21 and 23 exhibited strong inhibitory activities against α-glucosidase with IC50 values ranging from 0.10 to 0.62 mM, while the positive control acarbose had an IC50 value of 0.5 mM. All compounds showed no antibacterial or anti-phytopathogenic activity at the concentrations of 50 μg/mL and 1 mg/mL, respectively. These results indicated that isocoumarins will be useful to developing antioxidants and as diabetes control agents.

Keywords